BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial

Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis

(2016) Anna Baghdasaryan et al.   JOURNAL OF HEPATOLOGY

The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation

(2015) H. Graffner et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European study

(2015) V. S. Hegade et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

P1152 : A Comparative study of pruritus in PBC cohorts from UK, USA and Italy

(2015) V.S. Hegade et al.   JOURNAL OF HEPATOLOGY

Unmet clinical need in autoimmune liver diseases

(2015) Jessica K. Dyson et al.   JOURNAL OF HEPATOLOGY

RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial: Figure 1

(2015) Laura Jopson et al.   BMJ Open

Poster Session 1: Cholestasis and Autoimmune Liver Disease

(2014)   HEPATOLOGY

The New Epidemiology of Primary Biliary Cirrhosis

(2014) Laura Griffiths et al.   SEMINARS IN LIVER DISEASE

Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study

(2013) George F. Mells et al.   HEPATOLOGY

The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: Results of a double-blind, randomized, placebo-controlled trial

(2010) Edith M. M. Kuiper et al.   HEPATOLOGY

The 5-D itch scale: a new measure of pruritus

(2009) S. Elman et al.   BRITISH JOURNAL OF DERMATOLOGY

Primary biliary cirrhosis

(2009) Keith D. Lindor et al.   HEPATOLOGY

EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

(2009)   JOURNAL OF HEPATOLOGY